Intro

Easy 20–30 Minute Procedure

A quick, painless same-day surgery to help you achieve better vision.

Pre-Op Eye Exam

Before you schedule your EVO ICL procedure your doctor will perform a series of standard tests to measure your eye’s unique characteristics for the procedure. Once your doctor determines that the EVO ICL is a good option for you, they will educate you about the procedure and what to expect both during and after the procedure.

Getting Your EVO ICLs

When you arrive for your procedure your doctor will administer eye drops to dilate your pupils as well as anaesthetise your eyes.

Small Opening

To prepare for the implant your doctor will create one small opening at the base of your cornea to insert the EVO ICL lens. The procedure is painless because of the numbing medication.

Lens Insertion & Positioning

The EVO ICL lens then can be folded and inserted through the small incision your doctor has made. Once the lens is inserted the doctor will make any necessary adjustments to ensure proper positioning in the eye.

Returning Home

At this point, the procedure is over and many patients will have improved vision nearly immediately. Your doctor will prescribe more eye drops intended to aid in the healing process following the procedure. You will need someone to drive you home. Your doctor will tell you when your vision allows driving.

Cost blocks

How much does the EVO ICL procedure cost? Is it more expensive than LASIK?

EVO ICL and LASIK costs vary depending on various factors that may include your prescription, location and provider. Upon consultation with a EVO ICL doctor, they will provide you with your specific cost, financing options and payment plans.

On Average, contact lenses cost £10,000 Over a Lifetime.* Your personal cost will vary.

Because EVO ICL is a long-term solution, your procedure costs are generally fixed to a one-time fee. When you compare with the long-term costs of contact lenses, EVO ICL typically pays for itself.

*Popular daily disposable contacts, on average, cost about £500 a year. So over 20 years, a patient will spend £10,000 on contact lenses.

Candidate desktop

Who is a Good Candidate for EVO ICL?

EVO ICL Candidates

  • Are between the ages of 21 and 60 years.
  • Are short-sighted with mild to severe myopia (-0.5D to -20D).
  • Are long-sighted with mild to severe hyperopia (+0.5D to +10.0D)
  • Have astigmatism between 0.5 and 6.0 D
  • Have not had a change in prescription of more than .5D in a year.
  • Are looking for a procedure that doesn’t create dry eye syndrome

Real Life Stories From Real Life Patients

The thing that I love about ICLs is that they are putting a lens in there that can be removed.

Jennifer Puno, Web Designer

I feel like a big part of health is using what your body already has. ICLs is in line with that because it’s keeping your eye completely intact. My eye is still my eye.

Eve Torres Gracie, Jiu Jitsu Instructor

I would never be able to just wake up and go, and now I can literally just roll out of bed and go straight to the farmers market.

Sara Tso, Chef

There’s a few big road blocks to having glasses and being a photographer. Now I’ve got ICLs and I can run out and live my life unhindered.

Andrew Oxenham, Photographer

I had my first opportunity to put my ICLs eyes to the test recently in the Amazon rainforest, and it couldn't have been more exciting to be able to spot rare species better than ever.

Phil Torres, Entomologist, TV Show Host

2 Million+

Lenses Distributed

99.4%

Of people surveyed would have the procedure again¹

Ready to Discover Visual Freedom With EVO ICL? Find a Doctor Today

Important Safety Information

It is important to consider that EVO Visian® Implantable Collamer Lenses (ICL) are approved by the local health authority, which means they have been determined to be safe and effective. As with any procedure, there are risks to consider. If you have any questions or concerns it is always best to speak with a certified EVO Visian® Implantable Collamer Lens (ICL) doctor. The EVO Visian ICL family of lenses include EVO Visian ICL, EVO Visian Toric ICL, EVO+ Visian ICL, and EVO+ Visian Toric ICL and are designed for the correction/reduction of low to high myopia (-0.5 to -20.0 diopters (D)) and the correction/reduction of myopia in patients with up to -20 D of myopia with less than or equal to 6.0 D of astigmatism. The EVO Visian ICL family is indicated for use in phakic eye treatment and for: The correction/reduction of myopia in adults 21 – 60 years of age with power ranging from -0.5 D to -20.0 D at the spectacle plane. With an anterior chamber depth (ACD) equal to or greater than 3.0 mm, as measured from the corneal endothelium to the anterior lens capsule. This extended age range covering over 45 to 60 years of age only applies to the myopic EVO Visian ICL family, and only in countries covered by the jurisdiction of the EU Notified Bodies where the CE Mark is recognised (i.e., the EU, EEA, and EFTA). The EVO Visian ICL family of products currently in inventory do not have the updated Directions For Use (DFU) with this new wording yet, but it will be incorporated over time. EVO Visian ICL surgery does not eliminate the need for reading glasses, even if you have never worn them before. The EVO Visian ICL represents an alternative to other refractive surgeries including, laser assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), incisional surgeries, or other means to correct myopia such as contact lenses and eye glasses. The EVO Visian Toric ICL is intended to correct or reduce astigmatism (up to 6.0 D) you may have (the EVO Visian ICL is not intended to treat your astigmatism). Implantation of an EVO Visian ICL is a surgical procedure, and as such, carries potentially serious risks. The following represent potential complications/adverse reactions reported in conjunction with refractive surgery in general: additional surgeries, cataract formation, loss of best corrected vision, raised pressure inside the eye, loss of cells on the innermost surface of the cornea, conjunctival irritation, acute corneal swelling, persistent corneal swelling, endophthalmitis (total eye infection), significant glare and/or halos around lights, hyphaema (blood in the eye), hypopyon (pus in the eye), eye infection, Visian ICL dislocation, macular oedema, non-reactive pupil, pupillary block glaucoma, severe inflammation of the eye, iritis, uveitis, vitreous loss and corneal transplant. Before considering EVO Visian ICL surgery you should have a complete eye examination and talk with your eye care professional about EVO Visian ICL surgery, especially the potential benefits, risks and complications. You should discuss the time needed for healing after surgery.

References

Find a Doctor

References

1. Patient Survey, STAAR Surgical ICL Data Registry, 2018

2. Sanders D. Vukich JA. Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for Low Myopia. Cornea. 2006 Dec; 25(10):1139-46. Patient Survey, STAAR Surgical ICL Data Registry, 2018

3. Naves, J.S. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.

4. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.

5a. Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.

5b. Parkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.

*American Refractive Surgery Council